Hepatitis B Vaccination in Diabetes Care

In 2012 AADE issued a position statement regarding vaccination practices for hepatitis B, influenza and pneumoccoccal disease for people with diabetes. Two years later, in 2014, we partnered with GSK to survey diabetes educators on their vaccination practices, paticularly as it relates to hepatitis B. The goals of the survey were to determine the level of awareness among diabetes educators of the Centers for Disease Control and Prevention's recommendations to vaccinate adults with diabetes, how diabetes educators typically inform their patients and at what levels of awareness exists among AADE members' patients about vaccinations. Our survey found that three years after CDC recommendations, vaccination rates are still low, so through a call to action, AADE is encouraging  members to focus more on helping to prevent hepatitis B. This is particularly important as people with diabetes are two times as likely to be infected with this virus. Below is a written report on the findings and a visual representation. 


In This Section

Practice Resources

Related Resources